Mepolizumab-responsive Kimura disease

J Allergy Clin Immunol Pract. 2021 Jul;9(7):2928-2930. doi: 10.1016/j.jaip.2021.02.049. Epub 2021 Mar 5.

Authors

Manao Kinoshita¹, Youichi Ogawa², Misaki Onaka¹, Shinji Shimada¹, Tatsuyoshi Kawamura¹

Affiliations

¹ Department of Dermatology, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan.
² Department of Dermatology, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan. Electronic address: yogawa@yamanashi.ac.jp.

PMID: 33684634
DOI: 10.1016/j.jaip.2021.02.049

No abstract available

MeSH terms

Anti-Asthmatic Agents*
Antibodies, Monoclonal, Humanized / therapeutic use
Eosinophils
Humans
Kimura Disease*

Substances

Anti-Asthmatic Agents
Antibodies, Monoclonal, Humanized
mepolizumab